Cynthia S Chin Selected Research

Ionomycin

9/2004	Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
12/2003	Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model.
1/2002	Sentinel node mapping identifies vaccine-draining lymph nodes with tumor-specific immunological activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cynthia S Chin Research Topics

Disease

3	Neoplasms (Cancer) 09/2004 - 01/2002
1	Carcinoma (Carcinomatosis) 01/2002

Drug/Important Bio-Agent (IBA)

3	bryostatin 1IBA 09/2004 - 01/2002
3	Interleukin-2 (IL2)IBA 09/2004 - 01/2002
3	IonomycinIBA 09/2004 - 01/2002
2	VaccinesIBA 12/2003 - 01/2002
1	BryostatinsIBA 09/2004
1	Cancer VaccinesIBA 09/2004
1	CalciumIBA 09/2004
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 09/2004
1	AntigensIBA 09/2004
1	SuspensionsIBA 01/2002